CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Viet Nam Medicinal Materials JSC is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Viet Nam Medicinal Materials JSC
Khu 8 xa Phu Ninh, huyen Phu Ninh
PHU THO, Vietnam Ticker: DVMDVM

Business Summary
BRIEF: For the nine months ended 30 September 2024, Viet Nam Medicinal Materials JSC revenues increased 23% to VND1.173T. Net income decreased 6% to VND37.77B. Revenues reflect Sales Returns and Allowances decrease of 91% to VND46M. Net income was offset by Financial Income decrease of 22% to VND3.68B (income), Other Non-Operating Expense increase from VND138.8M to VND598M (expense), Depreciation in Selling Expenses increase of 10% to VND1.02B (expense).

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202412/31/2023Yes----

General Information
Number of Employees: 215 (As of 6/30/2024)
Outstanding Shares: 42,779,916 (As of 9/30/2024)
Stock Exchange: HST


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024